Login

Saundra Pelletier, CEO, Evofem Biosciences 00:00:00

Share On Facebook Share On Twitter

CEO Saundra Pelletier empowers women through Evofem’s healthcare products and business model

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Harnessing Industry 8.0 for Renewable Efficiency and Predictive Maintenance| Luca Bettonte, CEO,ERG SPA.
00:10:00
Alumni Spotlight: Joe Hete '76 | JOE HETE - Chief Executive Officer of Air Transport Services Group Inc.
00:10:00
Adani Wilmar Reports Robust Q2 Growth with EBDITA Surging 4x and Food & FMCG Boost | Angshu Mallick, CEO , Adani Wilmar Ltd.
00:10:00
Market Bounce and Long-Term Investment Strategies Amid Inflation and Interest Rate Changes
00:10:00
Genova Property Group's Interim Report Highlights for 2023 | Michael Moschewitz ,CEO , Genova Property Group AB.
00:10:00
Galena Mining: Advancing the Abra Base Metals Project in Western Australia
00:10:00
Hoskins, Managing Director of Graphics Mining: Developing Tanzania's Cello Graphite Project with Robust Economics and Market-Leading Strategy
00:10:00
Committed to building the ecosystem of capital|Elana Berkowitz,Founding Partner,Springbank Collective
00:10:00
Executive Chairman Justyn Peters Discusses Project Progress and Market Challenges | Daniel Justyn Douglas Peters, Chairman, Neurizer Ltd.
00:00:00
Shanda Blackmon, M.D., M.P.H. / Esophageal cancer is one of the deadliest cancers
00:10:00
The firm is focused on early stage digital consumer and enterprise|Annie Case,Partner,Kleiner Perkins
00:10:00
Remote Resilience: Lazard CEO on Dealmaking During Covid-19 | Kenneth M. Jacobs - Executive Chairman at Lazard Asset Management

© 2026 Nehu